New BlackBerry portfolio buyers have pedigree – but clock is ticking
The time and expense of launching an assertion programme in untested markets will limit the buyer’s ROI as well as incoming royalties
The time and expense of launching an assertion programme in untested markets will limit the buyer’s ROI as well as incoming royalties
Parent company Quarterhill is still undergoing a strategic review to determine whether to sell WiLAN, but doesn’t want the delay to remind anyone of the stagnant BlackBerry patent sale
The company has scrapped its failed $600 million deal with Catapult IP Innovations and now will seek US and Canadian government regulatory approval to close a $200 million pact
The partnership is aimed at helping the pharma giant to moentise deprioritised IP in the autoimmune space
04 July 2022
Life sciences innovators are increasingly paying for access to high-quality data
27 June 2022
John Chen says there’s a high probability that Catapult IP Innovations will still buy the portfolio, but he wants shareholders to know he’s “not just stuck with one option”
24 June 2022
After six years in charge, Paul Lin steps down to go solo, although he will remain an adviser to the Chinese company
23 June 2022
Although various government-led programmes have emerged over the years to encourage activity in the field, writes Joyce Ng, professionals reveal that a lack of transaction data and an absence of corporate buy-in is preventing it from going mainstream
22 June 2022
Despite the close attentions of a tornado and the deadening heatwave that preceded and followed it, delegates and speakers in Chicago were in good form for the final day of this year's event
15 June 2022
Collaboration with Innventure is the latest attempt to realise the value of innovations outside the company's strategic focus
14 June 2022
Latest data from AST points to a steep decline from the previous year’s numbers, but there are some indications that more licensing is being done
08 June 2022
Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital
06 June 2022
Scott Frank, President and CEO of the company’s IP operation, reveals how its team of patent developers takes a venture capital approach to interactions with inventors and lawyers to ensure the development of a highly diversified, revenue-generating, portfolio of rights
01 June 2022
Unlock unlimited access to all IAM content